William Callahan
Director/Board Member bij MEDISUN PRECISION MEDICINE LTD.
Profiel
William Callahan is an Independent Director at Medisun Precision Medicine Ltd.
since 2015.
He was a Senior Director-Manufacturing Operations at Talphera, Inc. and a Vice President-Operations at Assertio Therapeutics, Inc. from 2002 to 2012.
He obtained an undergraduate degree from San Francisco State University.
Actieve functies van William Callahan
| Bedrijven | Functie | Begin |
|---|---|---|
| MEDISUN PRECISION MEDICINE LTD. | Director/Board Member | 01-07-2015 |
Eerdere bekende functies van William Callahan
| Bedrijven | Functie | Einde |
|---|---|---|
Assertio Therapeutics, Inc.
 Assertio Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Assertio Therapeutics, Inc. engages in the manufacture and distribution of pharmaceutical products to treat pain and other central nervous system conditions. Its brands include Gralise, Zipsor, Lazanda, Cambia, NUCYNTA ER and NUCYNTA. The firm focuses on neurology, orphan and specialty medicines. The company was founded by John W. Shell on August 7, 1995 and is headquartered in Lake Forest, IL. | Chief Operating Officer | 01-02-2012 |
| TALPHERA, INC. | Corporate Officer/Principal | - |
Opleiding van William Callahan
| San Francisco State University | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| TALPHERA, INC. | Health Technology |
| Bedrijven in privébezit | 2 |
|---|---|
Assertio Therapeutics, Inc.
Assertio Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Assertio Therapeutics, Inc. engages in the manufacture and distribution of pharmaceutical products to treat pain and other central nervous system conditions. Its brands include Gralise, Zipsor, Lazanda, Cambia, NUCYNTA ER and NUCYNTA. The firm focuses on neurology, orphan and specialty medicines. The company was founded by John W. Shell on August 7, 1995 and is headquartered in Lake Forest, IL. | Health Technology |
Medisun Precision Medicine Ltd.
 Medisun Precision Medicine Ltd. BiotechnologyHealth Technology Medisun Precision Medicine Ltd. is a biotechnology company, which focuses on developing novel neurological therapies to be directly delivered into specific regions of the brain. It portfolio includes ACX-31 program to deliver two chemotherapy drugs, temozolomide in combination with BCNU, locally to brain tumor sites. The company was founded on August 29, 2012 and is headquartered in Majuro, Marshall Islands. | Health Technology |
